Part 2: Mucormycosis: Focus on Therapy.

Expert review of anti-infective therapy(2023)

引用 0|浏览1
暂无评分
摘要
Randomized, controlled therapeutic trials are lacking. Lipid formulations of amphotericin B (LFAB) are the mainstay of therapy but oral triazoles (posaconazole and isavuconazole) may be effective as step-down therapy, in MCR cases refractory to or intolerant of LFAB. We encourage early surgical debridement or excision as adjunctive measures.
更多
查看译文
关键词
Invasive fungal infections,mold,mucormycosis,Mucorales,amphotericin B,isavuconazole,posaconazole
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要